Ibrutinib in the Treatment of Relapsed Chronic Lymphocytic Leukemia
Aim. To estimate ibrutinib efficacy in the treatment of first early CLL relapses and in patients with ≥ 2 lines of preceding therapy. Analysis of treatment results in patients with del(17p) and monitoring of minimal residual disease (MRD) and ibrutinib safety profile. Materials & Methods. The ana...
Na minha lista:
| Principais autores: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Russo |
| Publicado em: |
Practical Medicine Publishing House
2018-01-01
|
| coleção: | Клиническая онкогематология |
| Assuntos: | |
| Acesso em linha: | https://bloodjournal.ru/index.php/coh/article/view/349 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|